Huons Global Co., Ltd. (KOSDAQ:084110)
 54,200
 +1,000 (1.88%)
  Oct 31, 2025, 1:40 PM KST
Huons Global Revenue
Huons Global had revenue of 212.66B KRW in the quarter ending June 30, 2025, with 1.43% growth. This brings the company's revenue in the last twelve months to 813.69B, up 1.43% year-over-year. In the year 2024, Huons Global had annual revenue of 813.46B with 7.26% growth.
Revenue (ttm) 
 813.69B
Revenue Growth 
 +1.43%
P/S Ratio 
 0.80
Revenue / Employee 
 6.90B
Employees 
 118
Market Cap 
647.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 813.46B | 55.08B | 7.26% | 
| Dec 31, 2023 | 758.38B | 94.01B | 14.15% | 
| Dec 31, 2022 | 664.36B | 89.72B | 15.61% | 
| Dec 31, 2021 | 574.65B | 51.60B | 9.87% | 
| Dec 31, 2020 | 523.05B | 73.62B | 16.38% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Samsung Biologics | 5.03T | 
| Celltrion | 3.75T | 
| Yuhan | 2.17T | 
| SK Biopharmaceuticals | 620.28B | 
| PharmaResearch | 449.81B | 
| Sam Chun Dang Pharm. | 215.10B | 
| ALTEOGEN | 158.06B | 
| LigaChem Biosciences | 148.28B |